Dr. Labhasetwar is a Professor of Biomedical Engineering at the Lerner Research Institute, Cleveland Clinic, with expertise in translational and clinical nanomedicine focused on cancer, CNS injuries, and cardiovascular diseases. His current research includes nanoparticle-based drug and gene delivery for cancer treatment and detection, antioxidant enzyme therapy for stroke and spinal cord injury, and vascular-targeted therapy to prevent post-angioplasty complications.
Vinod’s work also explores the role of cell membrane biophysics in drug transport and nanoparticle uptake, with recent efforts centered on epigenetic nanotherapy for drug-resistant and metastatic cancers. He has authored more than 160 peer-reviewed publications, holds several U.S. and international patents, and has received multiple honors, including Young Scientist, Distinguished Scientist, and Innovator awards.
He is a Fellow of the American Association of Pharmaceutical Scientists and was named a Highly Cited Researcher and Most Influential Mind in Science by Thomson Reuters. In 2014, he was awarded the Mahatma Gandhi Pravasi Samman Gold Medal for his contributions to science and technology at the House of Lords, UK. Dr. Labhasetwar is also the founding Editor-in-Chief of Drug Delivery and Translational Research, the official journal of the Controlled Release Society.